PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.54
ESG score 90-95% of RIGL's 61.48. Bill Ackman would demand clear ESG improvement catalysts.
57.89
Similar environmental score to RIGL's 59.96. Bruce Berkowitz would investigate if industry environmental norms adequately address climate transition risks.
58.17
Social score 80-90% of RIGL's 66.79. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
56.57
Similar governance score to RIGL's 57.69. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.